Rancho Santa Fe, CA, United States of America

David-Alexandre Gros

This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Imbria Pharmaceuticals, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David-Alexandre Gros. Retrieved from https://idiyas.com/inventor/david-alexandre-gros

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: David-Alexandre Gros: Innovator in Rheumatic Disease Treatment

Introduction

David-Alexandre Gros is a noted inventor based in Rancho Santa Fe, California. He has made significant contributions to the medical field, particularly in the treatment of rheumatic diseases. With a keen eye for innovation, Gros has developed a unique approach that holds promise for those suffering from these conditions.

Latest Patents

David-Alexandre Gros holds a patent for "Methods of treating rheumatic diseases using trimetazidine-based compounds." This invention provides compositions and methods for effectively treating subjects with rheumatic conditions, showcasing Gros's commitment to advancing medical science and improving patient outcomes.

Career Highlights

As an inventor, Gros has centered his career at Imbria Pharmaceuticals, Inc., where he has been able to apply his knowledge and skills to develop new therapeutic strategies. His work in the pharmaceutical industry illustrates the intersection of innovation and application in addressing complex health challenges.

Collaborations

Collaboration has been a vital element of David-Alexandre Gros's journey. He has worked closely with colleagues such as Andrew D. Levin and Jaikrishna Patel, contributing to a dynamic exchange of ideas and enhancing the development of groundbreaking treatments.

Conclusion

David-Alexandre Gros's inventive spirit and dedication to advancing the treatment of rheumatic diseases position him as a valuable asset in the pharmaceutical field. His innovative work continues to inspire and pave the way for new therapies that can potentially transform patient care in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…